- Home
- STSS vs ATRA Comparison
STSS vs ATRA Comparison
Compare STSS & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STSS | ATRA |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | 55 | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | STSS | ATRA |
|---|---|---|
| Price | $1.84 | $4.69 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 374.7K | 58.9K |
| Earning Date | 04-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.42 | $3.92 |
| 52 Week High | $18.23 | $19.15 |
Technical Indicators
Market Signals| Indicator | STSS | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 53.34 | 46.40 |
| Support Level | $1.66 | $4.70 |
| Resistance Level | $2.00 | $5.47 |
| Average True Range (ATR) | 0.08 | 0.31 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 43.75 | 29.69 |
Price Performance
Historical ComparisonAbout STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).